ArticleJournal of controlled release : official journal of the Controlled Release Society2018

Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.

Pilar de la Puente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.